Spinal cord injuries can at times be traumatic and ultimately lead to patients being paralyzed. One company is working on a technology that could see movement restored in patients suffering from these types of injuries, with a system that almost sounds like something out of a science fiction movie.

Deep brain stimulation (DBS) has been used to treat depression and a variety of different neurological disorders, but can it be used to help treat Alzheimer's disease? That's the question that Functional Neuromodulation (Charlottesville, Virginia) is hoping to answer in a new study designed to evaluate the use of DBS on Alzheimer's patients.

Integrated Diagnostics (Indi; Seattle), a molecular diagnostic company that was founded in 2009 and is focused on the use of blood-based proteomic tests, said it has raised $30.25 million from the closing of its Series B and $17 million in non-dilutive debt financing provided by Life Sciences Alternative Funding. The financing round was led by Baird Capital and joined by Indi's existing investors, InterWest Partners and the Wellcome Trust.

Endofotonics (Singapore), a firm that has spun off from the National University of Singapore (NUS) has developed a system that it says will make performing molecular diagnosis in the body a reality. The company said that its IMDX system, an in-vivo molecular diagnostic device, which has yet to gain approval, could potentially enable objective cancer diagnosis to be available almost instantaneously during endoscopy.